A novel chip-based parallel transfection assay to evaluate paracrine cell interactions.

The speed of gene function analyses in mammalian cells was significantly increased by the introduction of cell chip technology (reversely transfected cell microarray). However, the presently available technique is restricted to the analysis of autocrine effects of genes in the transfected cells. This limits the power of this method, as many genes are involved in heterotypic signaling both in physiologic and pathologic processes. At present, analyses of paracrine effects of transfected genes require trans-well or conditioned media approaches which are costly and time-consuming. Here, we present a novel method for the highly parallel analysis of paracrine gene functions on a chip. The basic idea was to adapt the cell chip technology to be performed with two different cell types which are differentially transfected: (1) an effector cell which is transfected with the genes of interest, and (2) an indicator cell in order to detect specific paracrine effects exerted from the transfected effector cells. Spot-to-spot diffusion of the paracrine mediators was prevented by matrix overlay, ultimately allowing 192 parallel tests for paracrine gene activations on one chip. In addition, we demonstrate the broad applicability and robustness of this technique using (1) various responder cell types, (2) various paracrine inducers, and (3) various indicator genes. The herein described approach allows for the first time a highly parallel analysis of paracrine gene functions and thus facilitates the characterization of genes involved in heterotypic cell communication in a broad range of research areas.

[1]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[2]  A. Albini,et al.  The guanylate binding protein‐1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP‐1 expression , 2003, The EMBO journal.

[3]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[4]  E. Kremmer,et al.  Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. , 2006, The American journal of pathology.

[5]  E. Kremmer,et al.  Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy , 2008, International journal of cancer.

[6]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[7]  H. Erfle,et al.  Reverse transfection on cell arrays for high content screening microscopy , 2007, Nature Protocols.

[8]  Prashanthi Karyala,et al.  Translational Up-Regulation and High-Level Protein Expression from Plasmid Vectors by mTOR Activation via Different Pathways in PC3 and 293T Cells , 2010, PloS one.

[9]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[10]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[11]  E. Kremmer,et al.  Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. , 2002, The American journal of pathology.

[12]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[13]  Carlo Riccardo Rossi,et al.  Tumor necrosis factor, cancer and anticancer therapy. , 2005, Cytokine & growth factor reviews.

[14]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[15]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[16]  F. Wurm,et al.  Large-scale transient expression in mammalian cells for recombinant protein production. , 1999, Current opinion in biotechnology.

[17]  E. Tartour,et al.  Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. , 1994, Cancer research.

[18]  M. Karin,et al.  Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression , 2004 .

[19]  Holger Erfle,et al.  High throughput screening of gene functions in mammalian cells using reversely transfected cell arrays: review and protocol. , 2008, Combinatorial chemistry & high throughput screening.

[20]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[21]  Peter Lichter,et al.  Functional screening for proapoptotic genes by reverse transfection cell array technology. , 2006, Genomics.

[22]  Thomas Werner,et al.  Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. , 2004, The Biochemical journal.

[23]  H. Erfle,et al.  A Systems Biology Approach To Identify the Combination Effects of Human Herpesvirus 8 Genes on NF-κB Activation , 2009, Journal of Virology.

[24]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[25]  H. Erfle,et al.  An RNAi screening platform to identify secretion machinery in mammalian cells. , 2007, Journal of biotechnology.

[26]  R. Durbin,et al.  Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes , 2010, Nature.

[27]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.